1228 (1228) News
Follow 1228 (1228) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
CANbridge Pharmaceuticals H1 revenue rises on Hunterase and Livmarli strength
CANbridge Pharmaceuticals says its H1 revenue rose, supported by Hunterase and Livmarli strength.
GEOPOLITICS | Aug 31, 2026, 04:33 AM UTC
M
CANbridge Pharmaceuticals revenue up 25.6% but net loss RMB37.1M
CANbridge Pharmaceuticals reported revenue up 25.6% and a net loss of RMB37.1M, with strategic investment and going-concern risks noted.
EQUITY | Aug 28, 2026, 09:45 AM UTC